APS BioGroup, Inc - 04/05/2018
Recipient: APS BioGroup, Inc United States Issuing Office: United States U.S. Food & Drug Administration PO Box 25087 Denver, CO 80225 April 5, 2018 WARNING LETTER CLOSE-OUT VIA UPS overnight Mr. George Stagnitti, President & CEO APS …